FDA Brief

Company record

Aurolab Trust

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Aurolab Trust.

Recalls

ReportedClassFirmProduct and reason
Oct 7 Class II Aurolab Trust
Drug
FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19
Lack of Assurance of Sterility